Overview


According to FutureWise analysis the market for animal biotechnology is expected to reach US$ 54.97 billion by 2031 at a CAGR of 9.40%.

Animal biotechnology is a part of biotechnology in which molecular biology approaches are used to genetically engineer animals for the purpose of improving their desirability for agricultural, industrial, or pharmaceutical applications. Animal biotechnology is used to produce genetically modified animals capable of synthesizing therapeutic proteins, exhibiting improved growth rates, and developing resistance to diseases. Animals have been used for years to produce medicines for human use. Animal-made pharmaceuticals transform genetically engineered animals into the factories to produce therapeutic proteins in the milk, eggs, and blood, which produce biopharmaceuticals. In addition, biotechnology has the potential to make human-compatible transplant organs, tissues, and cells, playing a vital role in advancing human healthcare.

Farmers have been improving livestock herds for decades through improved animal husbandry practices and modern technologies, such as artificial insemination, in vitro fertilization, embryo transfer, cloning, and genetic mapping. Through biotechnology, farmers can improve breeding, resulting in healthier herds. The animal health industry has also developed treatments that can prevent and treat disease. The advances in animal biotechnology have been greatly accelerated by advancements in sequencing animal genomes, studying gene expression, and profiling the metabolic processes of animal cells. One of the key breakthroughs has been the development of genome editing technologies such as Zinc Finger Nucleases, TALENS, and CRISPR-Cas systems. These cutting-edge tools have revolutionized the ability to introduce targeted genetic modifications in animals, improving health and well-being, enhanced agricultural production, and heightened resistance against diseases.

FutureWise Market Research has published a report that provides an insightful analysis animal biotechnology market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, animal biotechnology market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Zoetis
  • Boehringer Ingelheim International GmbH
  • Bayer AG
  • Intervet Inc
  • Sanofi
  • Santa Cruz Biotechnology

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent Developments in Animal Biotechnology Market:

  • In April 2022- Poultry vaccine maker Hester Bio entered pet care. The company wants to add dermatology, nutrition, grooming, anti-infective, and specialty products to the pet care segment.

  • In April 2022, Cadila Pharma launched one of the first novel 3-dose vaccines against rabies. The three-dose vaccine, named 'ThRabis,' is a recombinant nano-particle-based G protein vaccine that is prepared using Virus-like Particle technology.

The increasing incidence of animal diseases is expected to drive the significant demand for the animal biotechnology market. As livestock and companion animals are susceptible to various illnesses, there is a growing demand for advanced biotechnological solutions to combat these diseases effectively. Animal biotechnology offers innovative tools such as gene editing, genetic engineering, and diagnostics to enhance animal health, improve breeding practices, and develop novel therapeutics, driving the market's expansion. Moreover, the growing prevalence of advancements in cloning and the development of transgenic animals is expected to be a significant driver for expanding the animal biotechnology market. With the continuous progress in cloning techniques and the ability to introduce specific genes into animals, there is a surge in demand for transgenic animals that may be utilized for various research purposes, pharmaceutical production, and agricultural applications. These cutting-edge biotechnological approaches offer promising avenues for disease modeling, drug testing, and improved livestock traits, anticipated to fuel the market's growth during the forecast period. Furthermore, the high costs associated with R&D and implementation of animal biotechnology, particularly for smaller companies or regions with limited resources, may pose significant barriers, impeding the market's growth. The advanced equipment, specialized expertise, and stringent regulatory requirements in animal biotechnology may lead to substantial financial investments, which may be prohibitive for smaller players in the market. Additionally, the time-consuming and complex approval processes for new biotechnological products may hinder market growth, as they might delay the commercialization of innovative solutions.

By Animal

  • Livestock
    • Bovine
    • Porcine
    • Ovine
    • Poultry
    • Others
  • Companion
    • Canine
    • Feline
    • Equine
    • Aquatic
    • Avian
    • Others

By Type of Product

  • Drugs
  • Vaccinations
  • Diagnostic Tests
  • Genetic and Reproductive Products
  • Others

By Application

  • Diagnosis of Animal Diseases
  • Treatment of Animal Diseases
  • Preventive Care of Animals
  • Development of Animal Pharmaceuticals
  • Food Safety and Drug Development
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest revenue share in the market in 2022. Due to increased animal awareness levels and the enhancement of healthcare infrastructure, increase in the adoption of companion animals, the region is poised for significant growth. The prevalence of healthcare programs and a surge in initiatives to enhance animal health are expected to drive the expansion in this area. Additionally, the substantial R&D investments in North America are projected to further fuel the market growth. For instance, Zoetis Inc. took a notable step in October 2021 by expanding its manufacturing and development facility in Tullamore, Ireland, resulting in a significant boost in its capacity to produce veterinary monoclonal antibodies. Therefore, these above factors are expected to drive the target market during the forecast period.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Animal Biotechnology Market By Animal, By Type of Product, By Application and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to:sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1 . Years Considered for the Study
         3.2 . Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1 . Secondary Data
          1.1.1 . Key Data from Secondary Sources
         1.2 . Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Animal Biotechnology Market Variables, Trends and Scope
    •   1. Market LineProducts Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Lip Augmentation Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Animal Biotechnology Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Animal Biotechnology Market, By Animal Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Livestock
         1.1. Bovine
         1.2. Porcine
         1.3. Ovine
         1.4. Poultry
         1.5. Others
        2. Companion
         2.1. Canine
         2.2. Feline
         2.3. Equine
         2.4. Aquatic
         2.5. Avian
         2.6. Others

  • 8.   Animal Biotechnology Market, By Type of Product Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Drugs
        2. Vaccinations
        3. Diagnostic Tests
        4. Genetic and Reproductive Products
        5. Others

  • 9.   Animal Biotechnology Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Diagnosis of Animal Diseases
        2. Treatment of Animal Diseases
        3. Preventive Care of Animals
        4. Development of Animal Pharmaceuticals
        5. Food Safety and Drug Development
        6. Others

  • 10.   North America Animal Biotechnology Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Animal Biotechnology Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Animal Biotechnology Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Animal Biotechnology Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Zoetis
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Boehringer Ingelheim International GmbH
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Bayer AG
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Intervet Inc
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Sanofi
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Santa Cruz Biotechnology
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client

Related Market

Marine Biotechnology Market

Read More

Environmental Biotechnology Market

Read More

Biotechnology Market

Read More
Partner

Our Clients